106 related articles for article (PubMed ID: 6493047)
1. Effect of low-dose oral contraceptives on lipoproteins and lipolytic enzymes: differences between two commonly used preparations.
Leuven JA; Havekes L; van der Kooij-Pontier HA; Starmans RJ; Jansen H; Bouwhuis-Hoogerwerf ML; de Pagter HA; Hessel LW
Metabolism; 1984 Nov; 33(11):1039-42. PubMed ID: 6493047
[TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
3. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
Notelovitz M; Feldman EB; Gillespy M; Gudat J
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
[TBL] [Abstract][Full Text] [Related]
4. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
[TBL] [Abstract][Full Text] [Related]
5. Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?
Crona N; Silfverstolpe G; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1982; 105():41-4. PubMed ID: 6805244
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
7. The clinical and biochemical effects of two combination oral contraceptive agents.
Sapire KE; Berger GM; Maritz JS
S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
Larsson-Cohn U; Wallentin L; Zador G
Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive steroid effects on lipids and lipoproteins in cynomolgus monkeys.
Parks JS; Pelkey SJ; Babiak J; Clarkson TB
Arteriosclerosis; 1989; 9(2):261-8. PubMed ID: 2923583
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
[TBL] [Abstract][Full Text] [Related]
11. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
13. One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.
Luoma PV; Heikkinen JE; Ehnholm C; Ylöstalo PR
Eur J Clin Pharmacol; 1987; 31(5):563-7. PubMed ID: 3104057
[TBL] [Abstract][Full Text] [Related]
14. Effects of three different combinations of ethinyl estradiol and levonorgestrel on plasma lipids and high density lipoproteins.
Larsson-Cohn U; Wallentin L; Zador G
Acta Obstet Gynecol Scand Suppl; 1979; 88():57-60. PubMed ID: 230693
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives, lipoproteins, and atherosclerosis.
Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
17. Effects of ethinylestradiol/D-norgestrel combinations on serum lipoproteins.
Rössner S; Frankman O; Marsk L
Acta Obstet Gynecol Scand; 1980; 59(3):255-8. PubMed ID: 7424503
[TBL] [Abstract][Full Text] [Related]
18. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
Kuusi T; Nikkilä EA; Tikkanen MJ; Sipinen S
Atherosclerosis; 1985 Mar; 54(3):251-62. PubMed ID: 3158321
[TBL] [Abstract][Full Text] [Related]
19. [Changes in plasma lipids caused by oral contraceptives].
Kaffarnik H
Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
[No Abstract] [Full Text] [Related]
20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]